Male Breast Cancer Completed Phase 2 Trials for Bevacizumab (DB00112)

Back to Male Breast Cancer

Also known as: Breast Cancer, Male / Breast Cancer - Male / Breast cancer male / Cancer of male breast / Malignant neoplasm of male breast (disorder) / Carcinoma of male breast (disorder) / Breast cancer male NOS

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00017394
Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast CancerTreatment
NCT00119262
Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast CancerTreatment